Search results :

Vinorelbine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: L01CA04

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12
Aspartate aminotransferase increased 3% - 67% x x
Neutropenia 5% - 90% x x x x x x x x x x x
Leukopenia 0% - 99% x x x x x x x x x x x x
Agranulocytosis 1% - 96% x x x x x x x
Anaemia 1% - 87% x x x x x x x x x x x x
Stomatitis 15-16% x x x x x
Blood creatinine increased 5% - 28% x x
Fatigue 0% - 49% x x x x x x x x x x x
Lethargy 0% - 49% x x x x x x x x
Malaise 0% - 49% x x x x x x x x
Neurotoxicity 0% - 44% x x x x x x x x x x
Blood bilirubin increased 5% - 13% x x x x x x x x
Vomiting 0% - 60% x x x x x x x x x x x x
Asthenia 0% - 36% x x x x x x x x x x x
Creatinine increased 1% - 28% x x x x x x
Febrile neutropenia 0% - 11% x x x x x x x x x x
Nausea 0% - 57% x x x x x x x x x x x x
Respiratory tract infection 0% - 4% x x x x x x x x
Dyspnoea 0% - 7% x x x x x x x x x x x x
Constipation 0% - 35% x x x x x x x x x x x x
Injection site pain 0% - 16% x x x x x x x x x x x x
Hearing impaired postmarketing, 4% - 18% x x
Alopecia 0% - 30% x x x x x x x x x x x x
Diarrhoea 0% - 17% x x x x x x x x x x x x
Neuropathy peripheral 0% - 25% x x x x x x x x x x x x
Thrombocytopenia 0% - 21% x x x x x x x x x x x x
Injection site reaction 0% - 38% x x x x x x x x x x x
Ototoxicity 0% - 1% x x x x x x x x
Arthralgia postmarketing, 0% - 3% x x x x x x x x x x x x
Infection postmarketing, 0% - 5% x x x x x x x x x x x x
Dizziness 0% - 3% x x x x x x
Embolism 0% - 3% x x x x x x x x
Inappropriate antidiuretic hormone secretion 1% x
Numbness 0% - 7% x x x x x x x x
Paraesthesia 0% - 10% x x x x x x x x x x x x
Phlebitis 0% - 10% x x x x x x x x x x x x
Thrombosis 0% - 3% x x x x x x x x
Vertigo 0% - 3% x x x x x x
Weight decreased 0% - 21% x x x x x x x x
Cystitis haemorrhagic 1% x
Myalgia postmarketing, 0% - 3% x x x x x x x x x x x x
Local reaction 0% - 22% x x x x x x
Abdominal pain postmarketing x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x x
Angioedema postmarketing x x x x x x x x x x
Back pain postmarketing x x x x x x x x x x
Blister postmarketing x x x x x x x x x
Connective tissue disorder postmarketing x x x
Dysphagia postmarketing, 5% x x x x x x x x x x
Dermatitis postmarketing x x x x x x x x x x
Oesophagitis postmarketing x x x x x x x x x x
Rash postmarketing, 5% x x x x x x x x x x x x
Flushing postmarketing x x x x x x x x x x x x
Gastrointestinal disorder postmarketing x x x
Headache postmarketing, 5% x x x x x x x x x x
Cardiac disorder postmarketing x x x
Hypertension postmarketing x x x x x x x x x x x
Hyponatraemia postmarketing x x x x x x x x x x x
Hypotension postmarketing x x x x x x x x x x x
Immune system disorder postmarketing x x x
Nervous system disorder postmarketing x x x
Pancreatitis postmarketing x x x x x x x x x x
Pneumonia postmarketing x x x x x x x x x x
Pruritus postmarketing x x x x x x x x x x
Pulmonary oedema postmarketing x x x x x x x x x x x x
Pulmonary embolism postmarketing x x x
Skin disorder postmarketing x x
Tachycardia postmarketing x x x x x x x x x x
Urticaria postmarketing x x x x x x x x x x
Angiopathy postmarketing x x x
Vestibular disorder postmarketing x x
Deep vein thrombosis postmarketing x x x
Muscular weakness postmarketing x x x x x x x x x x
Skin necrosis postmarketing x x x x x x x x x
Pain in jaw postmarketing, 5% x x x x x x x x x x x x
Mucosal inflammation postmarketing x x x x x x x x x x
Electrolyte imbalance postmarketing x x
Injection site dermatitis postmarketing x x
Gait disturbance postmarketing x x x x x x x x x
Infestation NOS postmarketing x x x
Ear and labyrinth disorders postmarketing x x
Tumour pain postmarketing x x
Recall phenomenon postmarketing x x
Adenocarcinoma x x
Aplastic anaemia x
Angina pectoris x x
Anorexia 0% - 37% x x x x x x x x x x x
Arrhythmia x
Bacterial infection x
Bronchospasm x x x
Chest pain x x x x x x x x x x x x
Cough x
Diuresis x
Endocrine disorder x
Extravasation x x x
Body temperature increased 0% - 4% x x x x x x x x x x x
Cardiac failure x x
Hyperaesthesia x x
Hypersensitivity x x x x x x x x x
Hypoaesthesia x x x x x x x
Intestinal obstruction x x
Lung disorder x x
Mediastinal disorder x
Myocardial infarction x x x x x x x x x x x x
Necrosis x x x
Pain x x x x x x x x x x
Palpitations x
Ileus paralytic x x x x
Paresis x x x
Septicemia x
Cerebrovascular accident x x x x x x x x
Thrombophlebitis x
Erythema x x x x x x x x x x x x
Vasodilation x x x x x x x x
Small cell lung cancer x
Myocardial ischaemia x x x x x x x x
Bone marrow depression x
Hyporeflexia x x
Malnutrition x
Unspecified disorder of skin and subcutaneous tissue x
Acute pain x
Pain burning x
Ache x x x x x x x
Sepsis x x x x x x x x
Autonomic neuropathy x x
Hepatobiliary disease x
Peripheral coldness x
Transaminases increased 0% - 1% x x x x x x
Localized rash x x x x x x x x
Vein discolouration x x x x x x x x x x x x
Nephropathy toxic x x x x x x
Carcinoma of lung x
Hypoxemia x
Bilirubin total increased x x
Acute dyspnea x
Acute myocardial ischemia x
Blood and lymphatic system disorders x
Myelosuppression x x x x x x x x x
Thromboembolic event x
Neutropenic sepsis x x x x
Pulmonary toxicity x x
Myasthenia x x x
Gastrointestinal toxicity x
Respiratory failure x x
Ileus x x x x x x
Hepatic insufficiency x x x x x x x x
Radiation recall reaction (dermatologic) x
Chemical phlebitis x x x x x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Vinorelbine

Side effects:69
Source:BC Cancer

Vinorelbine

Side effects:81
Source:FDA Structured Product Label

VINORELBINE

Side effects:81
Source:FDA Structured Product Label

VINORELBINE

Side effects:81
Source:FDA Structured Product Label

VINORELBINE

Side effects:82
Source:FDA Structured Product Label

VINORELBINE

Side effects:82
Source:FDA Structured Product Label

VINORELBINE TARTRATE / NAVELBINE

Side effects:86
Source:FDA

VINORELBINE

Side effects:94
Source:FDA Structured Product Label

VINORELBINE

Side effects:95
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label